Although a trend to an increasing immunoreactivity was noted toward an ischemia duration of 24 h when compared to the earlier time point of 4 h, this study revealed consistently increased immunosignals of collagen IV and fibronectin up to 3 weeks following the ischemic event as exemplarily shown by the human stroke sections. The gene discussed is FN1; the disease is Stroke.